BOOKS BY CATEGORY
Your Account
Vaccines against Allergies
Price
Quantity
£166.50
(To see other currencies, click on price)
Paperback / softback
Add to basket  

£166.50
(To see other currencies, click on price)
Add to basket  

MORE ABOUT THIS BOOK

Main description:

We are celebrating this year the hundred years´ anniversary of allergen-specific immunotherapy. In 1911 Leonard Noon published his seminal work “Prophylactic inoculation against hay fever” describing his attempts to achieve active immunity against “grass pollen toxin” by administering increasing doses of grass pollen extract before the grass pollen season to allergic patients. Although it was unknown at that time that allergy represents an immunological hypersensitivity disease, the treatment was effective and many observations made by Noon remained valid until today. Today allergen-specific immunotherapy is well established as the only allergen-specific and disease-modifying treatment for IgE-mediated allergies and has long-lasting effects. In fact, more than 25% of the population suffer from IgE-mediated allergies which therefore represent a major health burden of our society, particularly because untreated allergy often progresses to severe disabling forms of disease, such as asthma and sometimes kills sensitized people through anaphylaxis.


Feature:

We are celebrating this year the hundred years´ anniversary of allergen-specific immunotherapy.

In 1911 Leonard Noon published his seminal work “Prophylactic inoculation against hay fever” describing his attempts to achieve active immunity against “grass pollen toxin” by administering increasing doses of grass pollen extract before the grass pollen season to allergic patients.

Although it was unknown at that time that allergy represents an immunological hypersensitivity disease, the treatment was effective and many observations made by Noon remained valid until today.


Back cover:

The pathomechanisms of allergy are quite well investigated and the disease-causing allergens are characterized in great detail down to their molecular structures. We are thus beginning to see several new strategies for allergen-specific immunotherapy on the horizon, several of which are summarized in this issue. It thus seems that hundred years after the first experimental attempts to “desensitize” hayfever patients we are now capable of developing powerful and rational forms of immunotherapy which hold promise for curing allergy sufferers and eventually may allow real prophylactic vaccination against allergy. It is thus quite possible that allergy may become eradicated similar as certain forms of infectious diseases through vaccination.


Contents:

Preface.- Immunological approaches for tolerance induction in allergy.- Clinical experience with recombinant molecules for allergy vaccination.- Allergen-specific immunotherapy with recombinant allergens.- Vaccine approaches for food allergy.- Intralymphatic immunotherapy: From the rationale to human applications.- Induction of allergen-specific tolerance via mucosal routes.- T cell epitope-based allergy vaccines.- Allergen-specific immunotherapy: Towards combination vaccines for allergic and infectious diseases.- Cell-based therapy in allergy.- Subject index.


PRODUCT DETAILS

ISBN-13: 9783642271007
Publisher: Springer (Springer Berlin Heidelberg)
Publication date: November, 2013
Pages: 170
Weight: 308g
Availability: POD
Subcategories: Immunology
Related books
Publisher recommends
Related books
From the same series

CUSTOMER REVIEWS

Average Rating